Midbrain Dopamine Neurons Defined by TrpV1 Modulate Psychomotor Behavior

Area of Science:

• Neuroscience
• Molecular Biology
• Neuropharmacology

Background:

• Ventral tegmental area (VTA) dopamine (DA) neurons are recognized for their heterogeneity.
• Transient Receptor Potential cation channel subfamily V member 1 (TrpV1) mRNA, typically associated with pain and heat, was unexpectedly found in the medial VTA.

Purpose of the Study:

• To investigate if TrpV1 expression defines a distinct subpopulation of VTA DA neurons.
• To characterize the molecular and anatomical features of these TrpV1+ neurons.
• To assess the behavioral relevance of TrpV1+ VTA neurons in response to amphetamine.

Main Methods:

• Histological analyses and Cre-driven mouse genetics were used to identify and study TrpV1+ neurons in the VTA.
• Co-localization studies examined the expression of TrpV1 with markers for dopamine (Tyrosine hydroxylase, Vesicular monoamine transporter 2) and glutamate (Vesicular glutamate transporter 2).
• A genetic strategy targeting the Vmat2 gene in TrpV1+ neurons was employed to assess behavioral changes.

Main Results:

• TrpV1 mRNA was detected in scattered neurons throughout the medial VTA and posterior hypothalamus, particularly at the perinatal stage.
• The majority of VTA TrpV1+ neurons co-expressed DA markers (Th, Vmat2) and a significant portion also co-expressed the glutamate marker Vglut2.
• These TrpV1+/Th+/Vglut2+/Vmat2+ neurons represent a distinct subpopulation co-releasing dopamine and glutamate.
• Genetic manipulation of Vmat2 in TrpV1+ neurons altered amphetamine-induced psychomotor behavior, causing acute hypersensitivity without progressive sensitization.

Conclusions:

• A distinct subpopulation of VTA DA neurons expressing TrpV1 was identified, characterized by co-release of dopamine and glutamate.
• These TrpV1+ VTA neurons play a critical role in modulating behavioral responses to amphetamine.
• The discovery of TrpV1 expression in VTA neurons offers potential for novel pharmacological interventions in this clinically important brain region.